These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 34261695)
1. Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma. Attalla K; DiNatale RG; Rappold PM; Fong CJ; Sanchez-Vega F; Silagy AW; Weng S; Coleman J; Lee CH; Carlo MI; Durack JC; Solomon SB; Reuter VE; Russo P; Chan TA; Motzer RJ; Schultz ND; Reznik E; Voss MH; Hakimi AA Clin Cancer Res; 2021 Oct; 27(20):5595-5606. PubMed ID: 34261695 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease Progression. Marcon J; DiNatale RG; Sanchez A; Kotecha RR; Gupta S; Kuo F; Makarov V; Sandhu A; Mano R; Silagy AW; Blum KA; Nassau DE; Benfante NE; Ortiz MV; Carlo MI; Chan TA; Motzer RJ; Voss MH; Coleman J; Russo P; Reuter V; Hakimi AA; Reznik E Clin Cancer Res; 2020 Jul; 26(14):3629-3640. PubMed ID: 32220885 [TBL] [Abstract][Full Text] [Related]
3. Tumour mutational burden, microsatellite instability, and actionable alterations in metastatic colorectal cancer: Next-generation sequencing results of TRIBE2 study. Antoniotti C; Korn WM; Marmorino F; Rossini D; Lonardi S; Masi G; Randon G; Conca V; Boccaccino A; Tomasello G; Passardi A; Swensen J; Ugolini C; Oberley M; Tamburini E; Casagrande M; Domenyuk V; Fontanini G; Giordano M; Abraham J; Spetzler D; Falcone A; Lenz HJ; Cremolini C Eur J Cancer; 2021 Sep; 155():73-84. PubMed ID: 34365081 [TBL] [Abstract][Full Text] [Related]
4. Putative Drivers of Aggressiveness in TCEB1-mutant Renal Cell Carcinoma: An Emerging Entity with Variable Clinical Course. DiNatale RG; Gorelick AN; Makarov V; Blum KA; Silagy AW; Freeman B; Chowell D; Marcon J; Mano R; Sanchez A; Attalla K; Weng S; Voss M; Motzer RJ; Russo P; Coleman JA; Reuter VE; Chen YB; Chan TA; Reznik E; Tickoo SK; Hakimi AA Eur Urol Focus; 2021 Mar; 7(2):381-389. PubMed ID: 31813809 [TBL] [Abstract][Full Text] [Related]
5. Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling. Pal SK; Ali SM; Yakirevich E; Geynisman DM; Karam JA; Elvin JA; Frampton GM; Huang X; Lin DI; Rosenzweig M; Lipson D; Stephens PJ; Ross JS; Miller VA; Agarwal N; Shuch B; Choueiri TK; Chung JH Eur Urol; 2018 Jan; 73(1):71-78. PubMed ID: 28592388 [TBL] [Abstract][Full Text] [Related]
6. Genomic Alterations of Renal Cell Carcinoma and Clinical Implications in the Chinese Population. Zhang S; Wang B; Zhang F; Ye J; Ge L; Ma L Med Sci Monit; 2019 Apr; 25():2959-2965. PubMed ID: 31007253 [TBL] [Abstract][Full Text] [Related]
7. Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study. Sanchez A; Furberg H; Kuo F; Vuong L; Ged Y; Patil S; Ostrovnaya I; Petruzella S; Reising A; Patel P; Mano R; Coleman J; Russo P; Liu CH; Dannenberg AJ; Chan TA; Motzer R; Voss MH; Hakimi AA Lancet Oncol; 2020 Feb; 21(2):283-293. PubMed ID: 31870811 [TBL] [Abstract][Full Text] [Related]
8. Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma. Becerra MF; Reznik E; Redzematovic A; Tennenbaum DM; Kashan M; Ghanaat M; Casuscelli J; Manley B; Jonsson P; DiNatale RG; Blum KA; Durack JC; Solomon SB; Arcila ME; Bourque C; Socci N; Carlo MI; Lee CH; Voss MH; Feldman DR; Motzer RJ; Coleman JA; Russo P; Cheng EH; Hakimi AA; Hsieh JJ Eur Urol Focus; 2018 Dec; 4(6):986-994. PubMed ID: 29066084 [TBL] [Abstract][Full Text] [Related]
9. Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets. Friedman CF; Ravichandran V; Miller K; Vanderbilt C; Zhou Q; Iasonos A; Vivek M; Mishra P; Leitao MM; Broach V; Sonoda Y; Kyi C; Zamarin D; O'Cearbhaill RE; Konner J; Berger MF; Weigelt B; Momeni Boroujeni A; Park KJ; Aghajanian C; Solit DB; Donoghue MTA Clin Cancer Res; 2023 Nov; 29(22):4660-4668. PubMed ID: 37643132 [TBL] [Abstract][Full Text] [Related]
10. Wide spetcrum mutational analysis of metastatic renal cell cancer: a retrospective next generation sequencing approach. Fiorentino M; Gruppioni E; Massari F; Giunchi F; Altimari A; Ciccarese C; Bimbatti D; Scarpa A; Iacovelli R; Porta C; Virinder S; Tortora G; Artibani W; Schiavina R; Ardizzoni A; Brunelli M; Knuutila S; Martignoni G Oncotarget; 2017 Jan; 8(5):7328-7335. PubMed ID: 27741505 [TBL] [Abstract][Full Text] [Related]
11. DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy. Ged Y; Chaim JL; DiNatale RG; Knezevic A; Kotecha RR; Carlo MI; Lee CH; Foster A; Feldman DR; Teo MY; Iyer G; Chan T; Patil S; Motzer RJ; Hakimi AA; Voss MH J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32571992 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive genomic profiling of metastatic collecting duct carcinoma, renal medullary carcinoma, and clear cell renal cell carcinoma. Bratslavsky G; Gleicher S; Jacob JM; Sanford TH; Shapiro O; Bourboulia D; Gay LM; Andrea Elvin J; Vergilio JA; Suh J; Ramkissoon S; Severson EA; Killian JK; Schrock AB; Chung JH; Miller VA; Mollapour M; Ross JS Urol Oncol; 2021 Jun; 39(6):367.e1-367.e5. PubMed ID: 33775530 [TBL] [Abstract][Full Text] [Related]
13. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer. Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687 [TBL] [Abstract][Full Text] [Related]
14. Genomic Alterations and Tumor Mutation Burden in Merkel Cell Carcinoma. Brazel D; Kumar P; Doan H; Pan T; Shen W; Gao L; Moyers JT JAMA Netw Open; 2023 Jan; 6(1):e2249674. PubMed ID: 36602798 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive Genomic Profiling of Metastatic Tumors in a Phase 2 Biomarker Study of Everolimus in Advanced Renal Cell Carcinoma. Gao X; Jegede O; Gray C; Catalano PJ; Novak J; Kwiatkowski DJ; McKay RR; George DJ; Choueiri TK; McDermott DF; Signoretti S; Bhatt RS Clin Genitourin Cancer; 2018 Oct; 16(5):341-348. PubMed ID: 29754934 [TBL] [Abstract][Full Text] [Related]
16. Noncoding RNA Expression and Targeted Next-Generation Sequencing Distinguish Tubulocystic Renal Cell Carcinoma (TC-RCC) from Other Renal Neoplasms. Lawrie CH; Armesto M; Fernandez-Mercado M; Arestín M; Manterola L; Goicoechea I; Larrea E; Caffarel MM; Araujo AM; Sole C; Sperga M; Alvarado-Cabrero I; Michal M; Hes O; López JI J Mol Diagn; 2018 Jan; 20(1):34-45. PubMed ID: 29056573 [TBL] [Abstract][Full Text] [Related]
17. A genomic mutation spectrum of collecting duct carcinoma in the Chinese population. Zhang H; Lu X; Huang G; Hua M; Zhang W; Wang T; Huang L; Wang Z; Chen Q; Li J; Yang Q; Yang G BMC Med Genomics; 2022 Jan; 15(1):1. PubMed ID: 34980126 [TBL] [Abstract][Full Text] [Related]
18. The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients. Zill OA; Banks KC; Fairclough SR; Mortimer SA; Vowles JV; Mokhtari R; Gandara DR; Mack PC; Odegaard JI; Nagy RJ; Baca AM; Eltoukhy H; Chudova DI; Lanman RB; Talasaz A Clin Cancer Res; 2018 Aug; 24(15):3528-3538. PubMed ID: 29776953 [No Abstract] [Full Text] [Related]
19. The genomic and transcriptomic landscape of advanced renal cell cancer for individualized treatment strategies. de Joode K; van de Geer WS; van Leenders GJLH; Hamberg P; Westgeest HM; Beeker A; Oosting SF; van Rooijen JM; Beerepoot LV; Labots M; Mathijssen RHJ; Lolkema MP; Cuppen E; Sleijfer S; van de Werken HJG; van der Veldt AAM Sci Rep; 2023 Jul; 13(1):10720. PubMed ID: 37400554 [TBL] [Abstract][Full Text] [Related]